DIA
Drug Information Association Logo
« Back to Listing

Improving Communication in the Informed Consent Process: The Advantages of eConsent

Track:
Processes and Technologies for Clinical Research

Day & Time:
June 17, 10:30AM - 12:00PM (Pacific Standard Time)

Session Number:
237

Room Number:
16A

Level:
Intermediate

Type:
Workshop

Title:
Improving Communication in the Informed Consent Process: The Advantages of eConsent

Chair(s):
Lindsay McNair, MD, MPH, MS
Chief Medical Officer
WIRB-Copernicus Group, United States

Description:
Informed consent is an ethical cornerstone of clinical research. This workshop will look at eConsent and how it can improve communication of information during the informed consent process.

**Due to workshop format, seating will be limited and will be available on a first come, first served basis.

The San Diego Convention Center has stringent regulations on maximum room capacities, and they are strictly enforced. Once all seats are occupied, DIA will be required to close the workshop, and no more participants will be admitted. Interested attendees are encouraged to arrive at workshops early in order to ensure seating. Please note, as a workshop with interactivity, this offering will not be recorded.

Learning Objective(s):
Discuss the technology of electronic informed consent; Identify the ethical issues associated with the informed consent process including how they are affected by eConsent; Identify the steps in implementing a clinical study using eConsent technology.

Presentation(s) & Speaker(s):
eConsent: An Advance in Communication and Ethics
Nicholas H. Steneck, PhD
Director, Research Ethics Program, Institute for Clinical and Health Research
University of Michigan, United States

The Sponsor's Experience: Managing an eConsent Pilot Study
Kamyar Farahi, PhD
Clinical Trials Lead
Janssen Scientific Affairs LLC, United States